LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics Market Cap

LENZ Therapeutics has a market cap or net worth of $401.39 million as of April 26, 2024. Its market cap has increased by 136.81% in one year.

• Market Cap: 401.39M
• Enterprise Value: 208.48M
• 1-Year Change: 136.81%
• Ranking: #3116
• Category: Small-Cap
• Stock Price: $15.72

Market Cap Chart

Since the IPO on June 25, 2021, LENZ Therapeutics's market cap has decreased from $951.31M to $401.39M, a decrease of -57.81%. That is a compound annual growth rate of -26.24%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	128.50M	-2.58%
Apr 24, 2024	131.90M	-0.38%
Apr 23, 2024	132.40M	0.15%
Apr 22, 2024	132.20M	-0.83%
Apr 19, 2024	133.30M	-8.38%
Apr 18, 2024	145.50M	-1.22%
Apr 17, 2024	147.30M	-11.10%
Apr 16, 2024	165.70M	-2.59%
Apr 15, 2024	170.10M	-6.59%
Apr 12, 2024	182.10M	0.72%
Apr 11, 2024	180.80M	3.31%
Apr 10, 2024	175.00M	2.58%
Apr 9, 2024	170.60M	0.41%
Apr 8, 2024	169.90M	0.47%
Apr 5, 2024	169.10M	-1.00%
Apr 4, 2024	170.80M	-3.23%
Apr 3, 2024	176.50M	0.97%
Apr 2, 2024	174.80M	-
Apr 1, 2024	174.80M	-5.92%
Mar 28, 2024	185.80M	2.43%
Mar 27, 2024	181.40M	30.22%
Mar 26, 2024	139.30M	2.58%
Mar 25, 2024	135.80M	0.74%
Mar 22, 2024	134.80M	-27.21%
Mar 21, 2024	185.20M	-2.73%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Travere Therapeutics	405.22M
CareDx	399.21M
Contineum Therapeutics	398.20M
Neurogene	395.49M
OraSure Technologies	395.18M
Lexicon Pharmaceuticals	389.05M
Mereo BioPharma Group	387.26M
iTeos Therapeutics	386.75M